News
Enter your email address to get Core One Labs News Alerts.
Company News
Core One Labs Vocan Expands Product Commercialization Team
April 06, 2021
Vancouver, British Columbia, Canada – April 6, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”)...
Read more
Company News
Core One Labs Completes Acquisition of Ketamine Infusions Centers of Texas Representing the Company’s First Psychedelics Clinic in the U.S. and Announces Fast Entry Inclusion in The Horizons Psychedelic ETF
March 31, 2021
Vancouver, British Columbia, Canada – March 31, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (“Core One” or the “Company”),...
Read more
Company News
Core One Labs Appoints Dr. Stephen Peach as Head of Patient Research
March 28, 2021
Vancouver, British Columbia, Canada – March 28, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) is pleased to announce...
Read more
Company News
Core One Labs Files Application to List its Common Shares on NASDAQ
March 20, 2021
Vancouver, British Columbia, Canada – March 20, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (“Core One” or the “Company”) is pleased to announce that it has filed...
Read more
Company News
Core One Labs to Commence Trading in the US on OTC Pink Market
March 14, 2021
Vancouver, British Columbia, Canada – March 14, 2021 – Core One Labs Inc. (CSE: COOL), (OTC Pink: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) a research and...
Read more
Company News
Psychedelic Expert Core One Labs Reports Milestone Acquisition The Developer of Psychedelic Treatments Enters the Telehealth Space with Access to Close to 80,000 Clinic Patients
March 12, 2021
Vancouver, British Columbia, Canada – March 12, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”)...
Read more